In this week’s episode, Dr. Sarah Stombaugh reviews the newest GLP medication: Foundayo. Foundayo (orforglipron) is a once-daily oral GLP medication, offering a potentially more convenient option for patients seeking medical support for weight loss.

Dr. Stombaugh breaks down the latest data from the ATTAIN clinical trials, explaining how effective this medication appears to be for weight loss and how it compares with existing GLP medications. She also reviews the most common side effects seen in the trials and what patients should realistically expect if they start treatment.

Finally, she discusses who may be a good candidate for this medication, situations where it may be particularly helpful, and what we currently know about cost and access. If you have been curious about new options for weight loss medications, this episode provides a clear and practical overview of what this new oral GLP may offer.

Ready to get started on your weight loss journey? We’re now enrolling patients for in-person visits in Charlottesville, Virginia and for telemedicine throughout the states of Illinois, Tennessee, and Virginia. Learn more and get started today at https://www.sarahstombaughmd.com

If you’re looking for support during your GLP journey, check out The GLP Guide. This on-demand video program will give you answers to the questions you have! Get started today at https://www.sarahstombaughmd.com/glp